The U.S. Food and Drug Administration and Centers for Disease Control and Prevention officially recommended on Aug. 12 and Aug. 13, 2021, respectively, that people who are moderately to severely immunocompromised receive ...
Aug 23, 2021
0
7
The most powerful tool for combating COVID is not a drug or a vaccine, but a method. A randomized trial is the best way to discover what works and what doesn't. This method underlies much of the progress in modern medicine, ...
Aug 23, 2021
0
5
Innovators at Purdue University and Houston Methodist Research Institute have created a novel strategy for developing an effective vaccine for a widespread form of tuberculosis.
Aug 20, 2021
0
259
A monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca reduced the risk of symptoms in a study of immunocompromised and chronically ill adults ...
Aug 20, 2021
0
150
(HealthDay)—A decision on booster shots for the approximately 13.8 million Americans who received Johnson & Johnson's single-shot coronavirus vaccine is likely to take weeks, according to people familiar with the issue.
Aug 20, 2021
0
32
Drug firm AstraZeneca on Friday announced positive results from a trial of a treatment for COVID-19 symptoms.
Aug 20, 2021
0
8228
A survey of more than 17,000 pregnant and lactating individuals who received the COVID-19 vaccine showed that the individuals did not experience symptoms any more severe than their non-pregnant counterparts.
Aug 17, 2021
0
11
COVID-19 breakthrough infections—where a fully vaccinated person becomes infected with the coronavirus—are occurring across the globe, due, in large part, to the highly contagious Delta variant. Here in the United States, ...
Aug 13, 2021
0
7
A South Australian-developed SARS-CoV-19 vaccine is preparing to progress to final stages of human clinical trials after early animal testing confirmed its safety and effectiveness in preventing COVID-19 lung infection.
Aug 12, 2021
0
5
Spain's medicines agency approved Tuesday a first round of clinical trials on humans for a COVID-19 vaccine developed by Spanish firm Hipra.
Aug 11, 2021
0
41
